Show simple item record

Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma

dc.contributor.authorWalsh, Garry Michael
dc.date.accessioned2013-03-15T10:29:01Z
dc.date.available2013-03-15T10:29:01Z
dc.date.issued2013-01-09
dc.identifier20890796
dc.identifier12123d6c-27d1-46f5-b329-ae02a2066ff2
dc.identifier.citationWalsh , G M 2013 , ' Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma ' , Biologics: Targets & Therapy , vol. 7 , pp. 7-11 . https://doi.org/10.2147/BTT.S30133en
dc.identifier.issn1177-5475
dc.identifier.urihttp://hdl.handle.net/2164/2709
dc.format.extent5
dc.format.extent146590
dc.language.isoeng
dc.relation.ispartofBiologics: Targets & Therapyen
dc.subjectIL-5en
dc.subjectasthmaen
dc.subjecteosinophilen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleProfile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthmaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.description.statusPeer revieweden
dc.identifier.doi10.2147/BTT.S30133


Files in this item

Thumbnail
Name:
Biologics_Targets_therapy_01_1 ...
Size:
143.1Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record